We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
MKS Inc
MKSI
$20.6B
| $502K | ﹤0.01% |
16,080
-8,288
| -34% | -$240K |
|
|
IPCC
827
DELISTED
Infinity Property & Casualty C
IPCC
| $496K | ﹤0.01% |
+7,377
| New | +$482K |
|
|
TIME
828
DELISTED
Time Inc.
TIME
| $489K | ﹤0.01% |
+20,191
| New | +$473K |
|
|
VWTR
829
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $487K | ﹤0.01% |
20,497
+5,683
| +38% | +$133K |
|
|
FARO
830
DELISTED
Faro Technologies
FARO
| $485K | ﹤0.01% |
9,878
-46,292
| -82% | -$2.12M |
|
|
COHR
831
DELISTED
Coherent Inc
COHR
| $478K | ﹤0.01% |
7,228
+4,062
| +128% | +$251K |
|
|
RST
832
DELISTED
ROSETTA STONE INC
RST
| $477K | ﹤0.01% |
49,102
-70,335
| -59% | -$735K |
|
833
Commercial Vehicle Group
CVGI
$147M
| $476K | ﹤0.01% |
+47,456
| New | +$451K |
|
834
Rogers Corp
ROG
$2.4B
| $472K | ﹤0.01% |
+7,117
| New | +$440K |
|
835
Teledyne Technologies
TDY
$32B
| $468K | ﹤0.01% |
+4,812
| New | +$460K |
|
836
WEX
WEX
$6.31B
| $468K | ﹤0.01% |
+4,454
| New | +$426K |
|
837
Wipro
WIT
$20B
| $466K | ﹤0.01% |
208,864
-9,511,627
| -98% | -$21.4M |
|
|
IPXL
838
DELISTED
Impax Laboratories, Inc.
IPXL
| $463K | ﹤0.01% |
15,448
-267,839
| -95% | -$7.23M |
|
839
Unifirst Corp
UNF
$5.25B
| $462K | ﹤0.01% |
4,360
-2,586
| -37% | -$255K |
|
840
BioCryst Pharmaceuticals
BCRX
$2.4B
| $459K | ﹤0.01% |
+36,011
| New | +$350K |
|
841
TETRA Technologies
TTI
$1.26B
| $459K | ﹤0.01% |
38,974
+11,147
| +40% | +$134K |
|
|
CLD
842
DELISTED
Cloud Peak Energy Inc
CLD
| $456K | ﹤0.01% |
+24,781
| New | +$486K |
|
|
TCF
843
DELISTED
TCF Financial Corporation Common Stock
TCF
| $452K | ﹤0.01% |
+16,091
| New | +$471K |
|
844
Univest Financial
UVSP
$1.18B
| $448K | ﹤0.01% |
+21,628
| New | +$432K |
|
845
Northwest Bancshares
NWBI
$2.28B
| $445K | ﹤0.01% |
32,810
-21,428
| -40% | -$294K |
|
|
EXL
846
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $432K | ﹤0.01% |
+32,423
| New | +$420K |
|
847
National Bank Holdings
NBHC
$1.9B
| $409K | ﹤0.01% |
+20,493
| New | +$401K |
|
848
Steris
STE
$23.1B
| $408K | ﹤0.01% |
+7,623
| New | +$393K |
|
|
PCYC
849
DELISTED
PHARMACYCLICS INC
PCYC
| $403K | ﹤0.01% |
4,496
-30,931
| -87% | -$2.9M |
|
850
Barrett Business Services
BBSI
$804M
| $402K | ﹤0.01% |
34,228
-30,168
| -47% | -$382K |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.